“…In the present study, edaravone treatment significantly reduced the oxidative stress serum markers dROM and the OS index, and Nrf2 expression in spinal motor neurons and LL myofibers (Figures d,e, , , ). It also reduced the expressions of PGC1α and HDAC4 in myofibers (Figure ), suggesting edaravone treatment enhanced mitochondrial function and muscle development (Loeffler et al, ; Petri et al, ; Thau et al, ). Furthermore, edaravone treatment ameliorated neurogenic myofiber atrophy, spinal motor neuron loss, astrogliosis and motor performance impairment measured by the rotarod test in Nrf2/G93A mice (Figures c, , ).…”